Effect of phenylalanine and its metabolites on the proliferation and viability of neuronal and astroglial cells: Possible relevance in maternal phenylketonuria

Journal of Pharmacology and Experimental Therapeutics

Volumn 295, Issue 1, 2000, Pages 295-301

  Oberdoerster, Jan ^a   Guizzetti, Marina ^a   Costa, Lucio G ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATROLACTIC ACID; LACTATE DEHYDROGENASE; MANDELIC ACID; PHENETHYLAMINE; PHENYLACETIC ACID; PHENYLPYRUVIC ACID; PROTEINASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL VIABILITY; CYTOTOXICITY; DNA SYNTHESIS; ENZYME INHIBITION; FEMALE; FETUS; FLOW CYTOMETRY; GENETIC DISORDER; GRANULE CELL; HUMAN; HUMAN CELL; MACROGLIA; MENTAL DEFICIENCY; MICROCEPHALY; NEUROBLASTOMA; NONHUMAN; NUTRITIONAL DEFICIENCY; PHENYLKETONURIA; PRIORITY JOURNAL; RAT;

ASTROCYTES; CELL DIVISION; CELL SURVIVAL; FEMALE; HUMANS; NEURONS; PHENETHYLAMINES; PHENYLALANINE; PHENYLKETONURIA, MATERNAL; PREGNANCY; THYMIDINE; TUMOR CELLS, CULTURED;

EID: 0033803887     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Reduced myelinogenesis and recovery in hyperphenylalaninemic rats. Correlation between brain phenylalanine levels, characteristic brain enzymes for myelination, and brain development
2. Effects of phenylalanine derivatives on the main regulatory enzymes of hepatic cholesterogenesis
3. Phenylalanine metabolites in phenylketonuria
4. Negative regulation of cell proliferation by mevalonate or one of the mevalonate phosphates
5. Suppression of the proliferation of Ras-transformed cells by fluoromevalonate, an inhibitor of mevalonate metabolism
6. Regulation of proliferation and Ras localization in transformed cells by products of mevalonate metabolism
7. Phenylacetate inhibits protein isoprenylation and growth of the androgen-independent LNCaP prostate cancer cells transfected with T24 Ha-ras oncogene
8. Phenylalanine and its metabolites induce embryopathies in mouse embryos in culture
9. Regulation of the mevalonate pathway
10. Branch-point reactions in the biosynthesis of cholesterol, dolichol, ubiquinone and prenylated proteins
11. Inhibition of muscarinic receptor-stimulated glial cell proliferation by ethanol
12. Acetylcholine as a mitogen: Muscarinic receptor-mediated proliferation of rat astrocytes and human astrocytoma cells
13. Phenylacetate inhibits isoprenoid biosynthesis and suppresses growth of human pancreatic carcinoma
14. Brain development in experimental hyperphenylalaninaemia: Myelination
15. An evaluation of the possible neurotoxicity of metabolites of phenylalanine
16. Abnormal cerebral cortical neurons in a child with maternal PKU syndrome
17. A synopsis of the unconjugated acidic transamination metabolites of phenylalanine in phenylketonuria
18. Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies
19. Maternal phenylketonuria: A metabolic teratogen
20. Maternal phenylketonuria: Magnetic resonance imaging of the brain in offspring
21. Maternal hyperphenylalaninemia fetal effects
22. Phenylacetate and brain dysfunction in experimental phenylketonuria: Synaptic development
23. Experimental maternal phenylketonuria: An examination of two animal models
24. Effect of excess phenylacetate diet during pregnancy on fetal brain growth in rats
25. Return to diet therapy in patients with phenylketonuria
26. Enhanced caspase activity during ethanol-induced apoptosis in rat cerebellar granule cells
27. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages
28. Long-term follow-up of children with classical phenylketonuria after diet discontinuation: A review
29. Lipid metabolism as a target for brain cancer therapy: Synergistic activity of lovastatin and sodium phenylacetate against human glioma cells
30. Retarded development of neurons and oligodendroglia in rat forebrain produced by hyperphenylalaninemia results in permanent deficits in myelin despite long recovery periods
31. Defects in metabolism of amino acids
32. Impairment of callosal and corticospinal system function in adolescents with early-treated phenylketonuria: A transcranial magnetic stimulation study
33. Selective activity of phenylacetate against malignant gliomas: Resemblance to fetal brain damage in phenylketonuria
34. Phenylketonuria metabolites in cerebellum culture morphology
35. Phenylalanine and phenylacetate adversely affect developing mammalian brain neurons
36. Acidic metabolites of phenylalanine in plasma of phenylketonurics
37. Neuropathology of phenylacetate poisoning in rats: An experimental model of phenylketonuria
38. Maternal phenylketonuria
39. Correlates of intelligence test results in treated phenylketonuric children